|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95.70 USD | +3.73% |
|
+9.25% | -6.31% |
| 05-08 | Guardant Health, Inc., Q1 2026 Earnings Call, May 07, 2026 | |
| 05-07 | Guardant Health Q1 Adjusted Loss Narrows, Revenue Rises; Raises Full-Year Revenue Guidance | MT |
Business description: Guardant Health, Inc.
Number of employees: 2,498
Sales by Activity: Guardant Health, Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Medical Labs & Research | 374M | 450M | 564M | 739M | 982M |
Geographical breakdown of sales: Guardant Health, Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
United States | 353M | 421M | 527M | 697M | 923M |
International | 21.09M | 28.92M | 37.42M | 41.85M | 58.74M |
Executive Committee: Guardant Health, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
AmirAli Talasaz
CEO | Chief Executive Officer | 46 | 04/08/2021 |
Helmy Eltoukhy
CEO | Chief Executive Officer | 47 | 31/12/2012 |
Michael Bell
DFI | Director of Finance/CFO | 57 | 04/01/2021 |
Peter Massaro
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gulshan Shaver
CMP | Compliance Officer | - | 30/04/2023 |
Composition of the Board of Directors: Guardant Health, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Helmy Eltoukhy
CHM | Chairman | 47 | 04/08/2021 |
AmirAli Talasaz
CHM | Chairman | 46 | 31/12/2012 |
Ian Clark
BRD | Director/Board Member | 65 | 30/11/2016 |
Vijaya Gadde
BRD | Director/Board Member | 51 | 31/05/2020 |
Meghan Joyce
BRD | Director/Board Member | 42 | 03/08/2021 |
Myrtle Potter
BRD | Director/Board Member | 67 | 14/10/2021 |
Steve Krognes
BRD | Director/Board Member | 57 | 29/06/2022 |
Musa Tariq
BRD | Director/Board Member | 43 | 05/03/2023 |
Manuel Medina
BRD | Director/Board Member | 58 | 16/07/2024 |
Roberto Mignone
BRD | Director/Board Member | 54 | 20/10/2024 |
Holdings: Guardant Health, Inc.
| Name | Equities | % | Valuation |
|---|---|---|---|
LUNIT INC. 3.31% | 1,229,794 | 3.31% | 26 M $ |
Company details: Guardant Health, Inc.
Diagnostic & Testing Substances
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.73% | +9.25% | +129.39% | +298.92% | 12.69B | |
| -0.63% | -0.84% | -38.87% | -25.06% | 9.87B | |
| +2.26% | +8.84% | +13.85% | -4.38% | 6.05B | |
| +0.49% | -1.70% | -8.63% | -7.33% | 5.48B | |
| -2.77% | +3.58% | +102.58% | +90.09% | 4.68B | |
| -18.60% | -12.56% | - | - | 4.57B | |
| -1.62% | +8.93% | -33.74% | -38.16% | 3.94B | |
| +1.73% | +1.82% | -13.03% | -38.66% | 2.87B | |
| -3.66% | -3.70% | +146.29% | -59.42% | 2.74B | |
| -0.52% | -3.94% | +13.01% | +42.00% | 1.67B | |
| Average | -1.96% | +0.39% | +34.54% | +28.67% | 5.46B | |
| Weighted average by Cap. | -0.97% | +2.15% | +40.56% | +70.95% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GH Stock
- Company Guardant Health, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition